Here, we present a comparison of multiple cellular model systems to study novel combinatorial treatments to overcome chemotherapy resistance in cervical cancers focusing on the inhibition of the metalloproteases ADAM10 and ADAM17. This evidence concerns the gene ADAM10 and cervical carcinoma.